Business Gilead to purchase cancer cells drugmaker Immunomedics for $21 billion By ronnie173 - September 14, 2020 0 2 Facebook Twitter Pinterest WhatsApp Loading .... (Reuters) – Gilead Sciences Inc will certainly obtain biopharmaceutical business Immunomedics Inc for $21 billion, a relocation that will certainly reinforce its cancer cells profile by acquiring acce … Read More Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Like this:Like Loading... Related